AdAlta (ASX:1AD) Share Price and News - StockTrack

Market Cap (19-Sep) $7,649,007 (1,598th)	Close (30-Jun) $0.024 0 (0%)	Volume (30-Jun) 2,170,184	Shortsold (2-Feb) 3,141 (0.00%) (662nd)
52w High $0.008	52w Low $0.002	P/E -	EPS 0

	Subject
	1AD 1AD Ann: Notification regarding unquoted securities - 1AD
	1 (current) 2 3
	1AD 1AD Ann: Results of Annual General Meeting
	1AD 1AD Ann: AGM presentations & first iCAR-T data
	1AD 1AD Ann: Cleansing Notice under Section 708A
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Second US patent for AD-214
	1AD 1AD Ann: Change in Director Interest Notice x 2 (PM & RP)
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Spark Plus engaged for SE Asia IR - shares in lieu of fees
	1AD 1AD Ann: R&D Tax Incentive Refund received
	1AD 1AD Ann: Notice of Annual General Meeting/Proxy Form
	1AD 1AD Ann: Virtual Meeting Voting and Registration Guide
	1AD 1AD Ann: Jobkeeper s323DB Notice
	1AD 1AD Ann: Change of Director's Interest Notice
	1AD 1AD Ann: Company Presentation - AusBiotech and Bio-Europe
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: BTB funding transferred to AD-214 inhalation program
	1AD 1AD Ann: Notification of Date of 2021 AGM
	1AD 1AD Ann: New pre-clinical data presented at Boston conference
	1AD 1AD Ann: Corporate overview and IRD Invest 2021 presentation
	1AD 1AD Ann: $4.0M Non-Dilutive Financing with Victorian Government
	1AD 1AD Ann: Appendix 4G and Corporate Governance Statement
	1AD 1AD Ann: Annual Report to shareholders
	1AD 1AD Ann: Preliminary Final Report
	1AD 1AD Ann: Carina collaboration webinar presentation
	1AD 1AD Ann: CAR-T collaboration with Carina Biotech
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: Webinar and presentation on AD-214 strategy
	1AD 1AD Ann: AD-214 pathway to IPF efficacy studies
	1AD 1AD Ann: Change in Director Interest Notice x 4
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: Operations Update & Cleansing Notice
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: AdAlta secures AD-214 resupply
	1AD 1AD Ann: R&D Tax Incentive Facility
	1AD 1AD Ann: Notification of Expiry of Listed Options - Correction
	1AD 1AD Ann: Notification of Expiry of Listed Options
	1AD 1AD Ann: AdAlta corporate presentation, upcoming events
	1AD 1AD Ann: GE Healthcare collaboration advances to next stage
	1AD 1AD Ann: AdAlta granted Japanese patent for AD-214
	1AD 1AD Ann: CSO presentation at ILD Drug Development Summit
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Mutiple Dose Part Of Ad-214 Phase I Trial Commenced
	1AD 1AD Ann: Appendix 3G
	1AD 1AD Ann: AdAlta Corporate Overview March 2021
	1AD 1AD Ann: Investor briefing-AD-214 top line single dose safety results
	1AD 1AD Ann: AdAlta to host investor briefing 10 March
	1AD 1AD Ann: Appendix 4D and Interim Financial Report

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	11,589,500	0.00 (0.00%)
12-Sep	$0.00	477,000	0.00 (0.00%)
11-Sep	$0.00	4,503,439	0.00 (0.00%)
05-Sep	$0.00	0	0.00 (0.00%)
04-Sep	$0.00	397,500	0.00 (0.00%)
03-Sep	$0.00	8,553,500	0.00 (25.00%)
29-Aug	$0.00	496,263	0.00 (0.00%)
28-Aug	$0.00	799,825	0.00 (20.00%)
22-Aug	$0.01	6,410,928	+0.00 (25.00%)
21-Aug	$0.00	2,372,593	+0.00 (60.00%)
15-Aug	$0.00	4,667,230	0.00 (0.00%)
14-Aug	$0.00	2,990,568	0.00 (16.67%)
07-Aug	$0.00	118	+0.00 (20.00%)
31-Jul	$0.00	75,962	+0.00 (25.00%)
30-Jul	$0.00	1,666,667	0.00 (0.00%)
4 up, 3 down, and 8 flat days

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

AdAlta Health Care

$0.024 (0%)

$0.024 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices